A new analysis of 2023 data conducted by the Indiana Primary Health Care Association (IPHCA) and Capital Link, highlights the transformative impact Community Health Centers have on Indiana's health and economic well-being. https://mma.prnewswire.com/media/2605826/IPHCA_Logo.jpg Key Highlights from the Report:Indiana's Community Health Centers play an essential role in providing access to high-quality, comprehensive primary care to Hoosiers. […]

Amidst the AI-driven landscape of passed CES 2025, smart home ecosystems are redefining consumer expectations.As a pioneering brandin the electronics industry, Toshiba TV continues to push the boundaries of innovation.The Toshiba TV REGZA AI-powered engines redefine home viewing-turning every screen into a smart, responsive canvas that understands and anticipates viewers' deepest entertainment cravings. https://mma.prnewswire.com/media/2382469/Toshiba_logo.jpg Embrace

Expansion into Europe marks continued evolution of successful CDR platform Today CIBC announced the expansion of its Canadian Depositary Receipts (“CDRs”) platform with the addition of five new “European CDRs”, to be listed on Cboe Canada and available for trading on January 31, 2025, subject to final approval by the Exchange. Introduced to investors over

The iconic burger brand introduces the ultimate union of two Canadianclassics Harvey's, the beloved Canadian destination for build-your-own flame-grilled burgers and signature poutine, is excited to unveil its newest menu innovation: FRINGS® Poutine. This mouth-watering creation combines its most popular sides- golden onion rings and crispy fries smothered in rich, savoury gravy and gooey cheese

(NasdaqGM:ADAG), Muzastotug (ADG126), an Anti-CTLA-4 SAFEbody(R) in Combination with pembrolizumab showed 33% overall response rate in microsatellite stable colorectal cancer Four confirmed partial responses out of twelve patients with 20 mg/kg loading dose followed by 10 mg/kg Q3W + pembrolizumab No Grade 4/5 treatment related adverse events were observed and no discontinuations occurred to date

(NYSE MKT:CANF),(TASE:CFBI),(TASE:CANF.TA), The Namodenoson oral drug is well positioned in the field of anti-obesity agents due to its activity and favorable safety profile Ramat Gan, Israel, Jan. 27, 2025 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory

(NASDAQ:GTBP), Initial data from the Phase 1 trial expected in 2025 SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager TriKE(R) platform, today announced that the first patient

(TSX-V:OCO),(Boerse Frankfurt – Freiverkehr:OR6),(OTC US:ORRCF),(Other OTC:ORRCF), VANCOUVER, Canada, Jan. 27, 2025 (GLOBE NEWSWIRE) — Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce a non-brokered private placement (the “Offering“) of up to 5,000,000 units of the Company (each, a “Unit“) at a price of C$0.30 per Unit for gross

(NASDAQ:TLRY),(TSX:TLRY), NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, is pleased to announce a series of game day events at its craft breweries nationwide, featuring premium craft brews paired with specially curated wing offerings designed specifically for game day

(CNSX:NVRO.CN),(OTC US:ESGLF),(Other OTC:ESGLF),(Frankfurt:YGK.F), TORONTO, Jan. 27, 2025 (GLOBE NEWSWIRE) — EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold,” or the “Company”), a clean technology company that monetises mine waste and tailings while reducing environmental and social liabilities, is pleased to announce it has executed a Memorandum of Understanding (the “MOU”) for